drugset / Trial / NCT05327127
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
RandomizedFactorialQuadruple-blindTreatment
Summary
A study to investigate the use of combination therapy with two investigational products for the treatment of adult patients with Nonalcoholic steatohepatitis (NASH).
Timeline
- Start
- 2022-11-14
- Primary completion
- 2026-05-20
- Completion
- 2026-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | K-877-ER | Unknown | — | — |
| Subject | TOFOGLIFLOZIN ANHYDROUS | Other / unclassified | — | — |